Nordic consensus statement on the systematic assessment and management of possible severe asthma in adults
Although a minority of asthma patients suffer from severe asthma, they represent a major clinical challenge in terms of poor symptom control despite high-dose treatment, risk of exacerbations, and side effects. Novel biological treatments may benefit patients with severe asthma, but are expensive, a...
Published in: | European Clinical Respiratory Journal |
---|---|
Main Authors: | , , , , , , , , , , , , , , , , , |
Format: | Text |
Language: | English |
Published: |
Taylor & Francis
2018
|
Subjects: | |
Online Access: | http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5844041/ http://www.ncbi.nlm.nih.gov/pubmed/29535852 https://doi.org/10.1080/20018525.2018.1440868 |
id |
ftpubmed:oai:pubmedcentral.nih.gov:5844041 |
---|---|
record_format |
openpolar |
spelling |
ftpubmed:oai:pubmedcentral.nih.gov:5844041 2023-05-15T16:50:10+02:00 Nordic consensus statement on the systematic assessment and management of possible severe asthma in adults Porsbjerg, Celeste Ulrik, Charlotte Skjold, Tina Backer, Vibeke Laerum, Birger Lehman, Sverre Janson, Crister Sandstrøm, Thomas Bjermer, Leif Dahlen, Barbro Lundbäck, Bo Ludviksdottir, Dora Björnsdóttir, Unnur Altraja, Alan Lehtimäki, Lauri Kauppi, Paula Karjalainen, Jussi Kankaanranta, Hannu 2018-03-06 http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5844041/ http://www.ncbi.nlm.nih.gov/pubmed/29535852 https://doi.org/10.1080/20018525.2018.1440868 en eng Taylor & Francis http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5844041/ http://www.ncbi.nlm.nih.gov/pubmed/29535852 http://dx.doi.org/10.1080/20018525.2018.1440868 © 2018 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group. http://creativecommons.org/licenses/by/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. CC-BY Review Article Text 2018 ftpubmed https://doi.org/10.1080/20018525.2018.1440868 2018-03-18T01:18:01Z Although a minority of asthma patients suffer from severe asthma, they represent a major clinical challenge in terms of poor symptom control despite high-dose treatment, risk of exacerbations, and side effects. Novel biological treatments may benefit patients with severe asthma, but are expensive, and are only effective in appropriately targeted patients. In some patients, symptoms are driven by other factors than asthma, and all patients with suspected severe asthma (‘difficult asthma’) should undergo systematic assessment, in order to differentiate between true severe asthma, and ‘difficult-to-treat’ patients, in whom poor control is related to factors such as poor adherence or co-morbidities. The Nordic Consensus Statement on severe asthma was developed by the Nordic Severe Asthma Network, consisting of members from Norway, Sweden, Finland, Denmark, Iceland and Estonia, including representatives from the respective national respiratory scientific societies with the aim to provide an overview and recommendations regarding the diagnosis, systematic assessment and management of severe asthma. Furthermore, the Consensus Statement proposes recommendations for the organization of severe asthma management in primary, secondary, and tertiary care. Text Iceland PubMed Central (PMC) Norway European Clinical Respiratory Journal 5 1 1440868 |
institution |
Open Polar |
collection |
PubMed Central (PMC) |
op_collection_id |
ftpubmed |
language |
English |
topic |
Review Article |
spellingShingle |
Review Article Porsbjerg, Celeste Ulrik, Charlotte Skjold, Tina Backer, Vibeke Laerum, Birger Lehman, Sverre Janson, Crister Sandstrøm, Thomas Bjermer, Leif Dahlen, Barbro Lundbäck, Bo Ludviksdottir, Dora Björnsdóttir, Unnur Altraja, Alan Lehtimäki, Lauri Kauppi, Paula Karjalainen, Jussi Kankaanranta, Hannu Nordic consensus statement on the systematic assessment and management of possible severe asthma in adults |
topic_facet |
Review Article |
description |
Although a minority of asthma patients suffer from severe asthma, they represent a major clinical challenge in terms of poor symptom control despite high-dose treatment, risk of exacerbations, and side effects. Novel biological treatments may benefit patients with severe asthma, but are expensive, and are only effective in appropriately targeted patients. In some patients, symptoms are driven by other factors than asthma, and all patients with suspected severe asthma (‘difficult asthma’) should undergo systematic assessment, in order to differentiate between true severe asthma, and ‘difficult-to-treat’ patients, in whom poor control is related to factors such as poor adherence or co-morbidities. The Nordic Consensus Statement on severe asthma was developed by the Nordic Severe Asthma Network, consisting of members from Norway, Sweden, Finland, Denmark, Iceland and Estonia, including representatives from the respective national respiratory scientific societies with the aim to provide an overview and recommendations regarding the diagnosis, systematic assessment and management of severe asthma. Furthermore, the Consensus Statement proposes recommendations for the organization of severe asthma management in primary, secondary, and tertiary care. |
format |
Text |
author |
Porsbjerg, Celeste Ulrik, Charlotte Skjold, Tina Backer, Vibeke Laerum, Birger Lehman, Sverre Janson, Crister Sandstrøm, Thomas Bjermer, Leif Dahlen, Barbro Lundbäck, Bo Ludviksdottir, Dora Björnsdóttir, Unnur Altraja, Alan Lehtimäki, Lauri Kauppi, Paula Karjalainen, Jussi Kankaanranta, Hannu |
author_facet |
Porsbjerg, Celeste Ulrik, Charlotte Skjold, Tina Backer, Vibeke Laerum, Birger Lehman, Sverre Janson, Crister Sandstrøm, Thomas Bjermer, Leif Dahlen, Barbro Lundbäck, Bo Ludviksdottir, Dora Björnsdóttir, Unnur Altraja, Alan Lehtimäki, Lauri Kauppi, Paula Karjalainen, Jussi Kankaanranta, Hannu |
author_sort |
Porsbjerg, Celeste |
title |
Nordic consensus statement on the systematic assessment and management of possible severe asthma in adults |
title_short |
Nordic consensus statement on the systematic assessment and management of possible severe asthma in adults |
title_full |
Nordic consensus statement on the systematic assessment and management of possible severe asthma in adults |
title_fullStr |
Nordic consensus statement on the systematic assessment and management of possible severe asthma in adults |
title_full_unstemmed |
Nordic consensus statement on the systematic assessment and management of possible severe asthma in adults |
title_sort |
nordic consensus statement on the systematic assessment and management of possible severe asthma in adults |
publisher |
Taylor & Francis |
publishDate |
2018 |
url |
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5844041/ http://www.ncbi.nlm.nih.gov/pubmed/29535852 https://doi.org/10.1080/20018525.2018.1440868 |
geographic |
Norway |
geographic_facet |
Norway |
genre |
Iceland |
genre_facet |
Iceland |
op_relation |
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5844041/ http://www.ncbi.nlm.nih.gov/pubmed/29535852 http://dx.doi.org/10.1080/20018525.2018.1440868 |
op_rights |
© 2018 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group. http://creativecommons.org/licenses/by/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
op_rightsnorm |
CC-BY |
op_doi |
https://doi.org/10.1080/20018525.2018.1440868 |
container_title |
European Clinical Respiratory Journal |
container_volume |
5 |
container_issue |
1 |
container_start_page |
1440868 |
_version_ |
1766040339018153984 |